SCHEMBL7075671

SCHEMBL7075671

ON=C(c1ccc(Nc2cccnc2)cc1Cl)c1sccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.38
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
NPC1 O15118 3/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
KIF11 P52732 1/20 0.36
RAB9A P51151 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP11B2 P19099 3/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.34
CSF1R P07333 2/20 0.34
GRM5 P41594 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7075667 1.00 NAMPT (0.38) NAMPTMEN1KMT2ANPC1LMNA
SCHEMBL7076724 0.86 MAPK13 (0.45) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL7076728 0.86 MAPK13 (0.45) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL7079820 0.84 MEN1 (0.44) NAMPTMEN1KMT2ANPC1LMNA
SCHEMBL7083156 0.84 NAMPT (0.44) NAMPTMEN1KMT2ANPC1LMNA
SCHEMBL7035784 0.79 MAPK14 (0.52) MEN1KMT2ANPC1RAB9ACYP11B2
SCHEMBL7081225 0.78 ADRA2A (0.42) MAPTALDH1A1GAA
SCHEMBL7081224 0.78 ADRA2A (0.42) MAPTALDH1A1GAA
SCHEMBL7076530 0.76 MAPK14 (0.53) MEN1KMT2ALMNAMAPTKDM4E
SCHEMBL7076531 0.76 MAPK14 (0.53) MEN1KMT2ALMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 NAMPT 2046/4885MEN1 4824/4885KMT2A 1701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.